SC
BEAT

Sophrosyne Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Sophrosyne Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-432,853
Closed -$4.08M – 16
2015
Q2 		$4.08M Sell
432,853
-394,451
-48% -$3.65M 30.55% 1
2015
Q1 		$7.32M Sell
827,304
-224,838
-21% -$2.27M 12.56% 1
2014
Q4 		$10.6M Sell
1,052,142
-74,832
-7% -$642K 16.27% 1
2014
Q3 		$7.56M Sell
1,126,974
-29,000
-3% -$203K 8.92% 2
2014
Q2 		$8.29M Buy
1,155,974
+57,800
+5% +$460K 8.44% 1
2014
Q1 		$11.1M Sell
1,098,174
-133,544
-11% -$1.23M 9.71% 1
2013
Q4 		$9.78M Buy
1,231,718
+218,400
+22% +$2.04M 8.57% 1
2013
Q3 		$10M Sell
1,013,318
-932,354
-48% -$7.34M 6.64% 3
2013
Q2 		$11.5M Buy
+1,945,672
New +$6.55M 9% 1

Other funds holding BEAT

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAD
Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Sophrosyne Capital's BEAT Position: Q3 2015 in Review

Sophrosyne Capital sold out of BioTelemetry, Inc. (BEAT) in Q3 2015, closing a stake of 432,853 shares — an estimated $4.08M sold.

Sophrosyne Capital first reported a position in BEAT in Q2 2013 and held it in 9 quarters. The position peaked at $11.5M in Q2 2013. 119 funds tracked by Wall St. Rank hold BEAT as of Q3 2015.

  • Sophrosyne Capital reported no remaining BioTelemetry, Inc. position as of Q3 2015 after selling out during the quarter.
  • Sophrosyne Capital sold 432,853 BioTelemetry, Inc. shares in Q3 2015, an estimated $4.08M.
  • Sophrosyne Capital first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 9 quarters.
  • Sophrosyne Capital's BioTelemetry, Inc. position peaked at $11.5M in Q2 2013.
  • 119 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2015.

Based on Sophrosyne Capital's 13F filing for Q3 2015, filed 13 Nov 2015.